{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T21:39:47Z","timestamp":1763415587195,"version":"3.45.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"vor","delay-in-days":387,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.jtct.2022.01.023","type":"journal-article","created":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T18:50:15Z","timestamp":1643827815000},"page":"276.e1-276.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of Human T Cell Lymphotropic Virus Type 1 and 2 Infection on Survival Following Stem Cell Transplantation"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9923-1519","authenticated-orcid":false,"given":"Vishal K.","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Areej","family":"El-Jawahri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grigori","family":"Orkev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam H.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3503-0061","authenticated-orcid":false,"given":"Janice","family":"Weinberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Courtney","family":"Goodrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9323-8007","authenticated-orcid":false,"given":"Murali","family":"Janakiram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7069-4528","authenticated-orcid":false,"given":"John Mark","family":"Sloan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2022.01.023_bib0001","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3389\/fmicb.2012.00388","article-title":"Epidemiological aspects and world distribution of HTLV-1 infection","volume":"3","author":"Gessain","year":"2012","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jtct.2022.01.023_bib0002","first-page":"336","article-title":"HTLV-1 and associated adult T-cell leukemia\/lymphoma","volume":"7","author":"Mahieux","year":"2003","journal-title":"Rev Clin Exp Hematol"},{"issue":"suppl 1","key":"10.1016\/j.jtct.2022.01.023_bib0003","doi-asserted-by":"crossref","first-page":"05","DOI":"10.1186\/1742-4690-12-S1-O5","article-title":"Estimating the number of HTLV-2 infected persons in the world","volume":"12","author":"Murphy","year":"2015","journal-title":"Retrovirology"},{"key":"10.1016\/j.jtct.2022.01.023_bib0004","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/j.1537-2995.2006.00788.x","article-title":"Effectiveness of human T-lymphotropic virus (HTLV) recipient tracing (lookback) and the current HTLV-I and -II confirmatory algorithm, 1999 to 2004","volume":"46","author":"Stramer","year":"2006","journal-title":"Transfusion"},{"key":"10.1016\/j.jtct.2022.01.023_bib0005","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.hoc.2016.11.005","article-title":"Adult T-cell leukemia\/lymphoma: a problem abroad and at home","volume":"31","author":"Dittus","year":"2017","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.jtct.2022.01.023_bib0006","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/clinids\/21.4.992","article-title":"Development of human T-cell lymphotropic virus type I-associated adult T-cell leukemia\/lymphoma during immunosuppressive treatment following renal transplantation","volume":"21","author":"Jenks","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jtct.2022.01.023_bib0007","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1159\/000168722","article-title":"Adult T-cell leukemia\/lymphoma in a renal transplant recipient: an opportunistic occurrence","volume":"14","author":"Williams","year":"1994","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.jtct.2022.01.023_bib0008","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ajh.2830410414","article-title":"Adult T-cell leukemia developing during immunosuppressive treatment in a renal transplant recipient","volume":"41","author":"Tsurumi","year":"1992","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtct.2022.01.023_bib0009","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1056\/NEJMc053295","article-title":"Donor-derived T-cell leukemia after bone marrow transplantation","volume":"354","author":"Tamaki","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2022.01.023_bib0010","doi-asserted-by":"crossref","first-page":"E317","DOI":"10.1002\/ajh.25631","article-title":"Safety of autologous stem cell transplantation in patients with known human T-cell lymphotropic viruses type 1 and 2 infection: a case series of four patients","volume":"94","author":"Gupta","year":"2019","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtct.2022.01.023_bib0011","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4269\/ajtmh.1999.60.146","article-title":"Strongyloides stercoralis hyperinfection associated with human T cell lymphotropic virus type-1 infection in Peru","volume":"60","author":"Gotuzzo","year":"1999","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jtct.2022.01.023_bib0012","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.bbmt.2016.05.017","article-title":"Mogamulizumab treatment prior to allogeneic hematopoietic stem cell transplantation induces severe acute graft-versus-host disease","volume":"22","author":"Sugio","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.01.023_bib0013","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S2352-4642(19)30024-0","article-title":"Transmission of CMV, HTLV-1, and HIV through breastmilk","volume":"3","author":"Prendergast","year":"2019","journal-title":"Lancet Child Adolesc Health"},{"issue":"suppl 1","key":"10.1016\/j.jtct.2022.01.023_bib0014","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1182\/blood-2020-140999","article-title":"Poor treatment outcomes of young (<60 Years) African American patients (Pts) diagnosed with acute myeloid leukemia (AML) (Alliance)","volume":"136","author":"Bhatnagar","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.01.023_bib0015","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/cncr.32556","article-title":"Epidemiology and survival trend of adult T-cell leukemia\/lymphoma in the United States","volume":"126","author":"Shah","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.jtct.2022.01.023_bib0016","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/s41379-018-0037-3","article-title":"Adult T-cell leukemia\/lymphoma can be indistinguishable from other more common T-cell lymphomas. The University of Miami experience with a large cohort of cases","volume":"31","author":"Khanlari","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jtct.2022.01.023_bib0017","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jcv.2009.03.012","article-title":"Age and gender specific prevalence of HTLV-1","volume":"45","author":"Eshima","year":"2009","journal-title":"J Clin Virol."}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636722000513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636722000513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:02:31Z","timestamp":1763002951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636722000513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S2666636722000513"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2022.01.023","relation":{},"ISSN":["2666-6367"],"issn-type":[{"type":"print","value":"2666-6367"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Human T Cell Lymphotropic Virus Type 1 and 2 Infection on Survival Following Stem Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2022.01.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}